One of the blogs I’ve really valued over the years was written by a pseudonymous academic blogger called DrugMonkey, but for two months the Monkey’s blog has been silent. Has he called it a day? Dropped the mic after successfully having big impact? What’s the deal? After many years could it be that the DrugMonkey decided to move on to focus on other things? He provided valuable, no-B.S. perspectives on science and in particular on NIH funding. There was also the occasional post on the science of …Read More
Below are 16 Science Twitter accounts that I think are musts to follow for those interested in transformative science and also medicine from a wide range of diverse, thought-provoking perspectives. I could list 160, but I’ve picked these 16 as a nice sampling with a lean towards those willing to take a risk in what they say or with unique views.
Here are some weekend science reads for you. A new type of “magic” mushroom? MIT Tech Review on lack of oversight of new GMO foods coming to your plate. DrugMonkey’s piece on lab labor and specifically whether undergrads “count” drew a lot of comments there. Of course they count in my view.
It’s a shame that National Geographic (NatGeo) has become part of a corporate empire that is not always consistent, to put it nicely, with data-based reality. Can NatGeo maintain its credibility and impact, when it is owned by a climate change denier (quoted for example as dissing folks as “extreme greenies”) who also has other very non-scientific priorities? There’s been an increasing amount of discussion of the technology that could produce GM humans. This dialogue includes the new Hinxton Statement (my take on that here) and …Read More